Back to search

Why Do So Many Cancer Patients Fail to Respond to Interferon Therapy?

Data up to Jan 2025

Published1996
Citations101
References73

Total Citations Per Year

Abstract

References (73)

Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins

1994 • 5,932 citations

Angiogenesis.

1992 • 2,581 citations

Cell Cycle Control and Cancer

1994 • 2,575 citations

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

1986 • 2,490 citations

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients

1990 • 1,544 citations

Cytokine therapeutics: lessons from interferonalpha.

1994 • 703 citations

Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia

1978 • 593 citations

Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.

1995 • 574 citations

Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1

1994 • 490 citations

Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2a

1989 • 444 citations

Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

1993 • 436 citations

Quantitative studies on viral interference in suspended L cells

1962 • 395 citations

Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated

1990 • 377 citations

Mechanism of the Antitumour Effect of Interferon in Mice

1972 • 317 citations

ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA

1988 • 261 citations

Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies

1988 • 251 citations

Stromal Involvement In Malignant Growth

1988 • 225 citations

Enhanced expression of β 2 -microglobulin and HLA antigens on human lymphoid cells by interferon

1978 • 215 citations

Neutralizing Antibodies to Interferon- : Relative Frequency in Patients Treated with Different Interferon Preparations

1991 • 214 citations

Enhancement by Interferon of the Expression of Surface Antigens on Murine Leukemia L 1210 Cells

1973 • 204 citations

Microvascular Injury in Pathogenesis of Interferon-Induced Necrosis of Subcutaneous Tumors in Mice

1989 • 192 citations

Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription.

1993 • 189 citations

Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administration

1988 • 184 citations

Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

1991 • 163 citations

Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro

1978 • 154 citations

An Update of the Medical Treatment of Malignant Endocrine Pancreatic Tumors

1993 • 142 citations

A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.

1985 • 139 citations

Interferon and Cell Division. IX. Interferon-Resistant L1210 Cells: Characteristics and Origin2

1974 • 132 citations

JAK protein tyrosine kinases: their role in cytokine signalling

1994 • 125 citations

Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products

1988 • 124 citations

Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells

1983 • 119 citations

How Cells Cycle Toward Cancer

1994 • 117 citations

He's Not Going to Talk About In Vitro Predictive Assays Again, Is He?

1990 • 115 citations

Interferon-activated signal transduction to the nucleus

1994 • 108 citations

Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor.

1985 • 97 citations

Is Interferon Tissue Specific? -- Effect of Human Leukocyte and Fibroblast Interferons on the Growth of Lymphoblastoid and Osteosarcoma Cell Lines

1977 • 92 citations

Chronic B-lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro

1986 • 90 citations

Cytokine triggered molecular pathways that control cell cycle arrest

1992 • 89 citations

Cells resistant to interferon are defective in activation of a promoter-binding factor.

1988 • 83 citations

Apoptosis in Burkitt lymphoma cells is driven by c-myc.

1993 • 77 citations

The EBNA2-related resistance towards alpha interferon (IFN-alpha) in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF-3.

1992 • 73 citations

Interferon-gamma induction of LFA-1-mediated homotypic adhesion of human monocytes.

1986 • 72 citations

Circulating Human Interferon after Intramuscular Injection into Animals and Man

1974 • 70 citations

In Vivo Sensitivity and Resistance of Chronic Myelogenous Leukemia Cells to a-Interferon: Correlation with Receptor Binding and Induction of 2, 5-Oligoadenylate Synthetase

1986 • 68 citations

Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

1993 • 68 citations

Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours

1990 • 66 citations

Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemia

1991 • 63 citations

Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon‐induced enhancement of natural killer activity and clinical response to human interferon‐α

1982 • 63 citations

Correlation between in vitro and in vivo sensitivity to human leucocyte interferon in patients with multiple myeloma

1985 • 61 citations

Effective natural interferon-alpha therapy in recombinant interferon- alpha-resistant patients with hairy cell leukemia

1991 • 58 citations

Cytolytic activity of interferon‐gamma and its synergism with 5‐fluorouracil

1984 • 57 citations

Treatment of anti‐recombinant interferon‐alpha 2 antibody positive CML patients with natural interferon‐alpha

1991 • 56 citations

Interferon treatment of human malignancies - a short review

1993 • 50 citations

High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)

1988 • 48 citations

Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia‐a pilot study

1987 • 45 citations

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl‐2 oncoprotein

1995 • 40 citations

Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon- stimulated gene factor 3

1994 • 39 citations

Isolation of Daudi Cells with Reduced Sensitivity to Interferon.: I. Characterization

1983 • 39 citations

Treatment of neuroendocrine tumors

1994 • 35 citations

Interferon-γ (IFN-γ) Induces Programmed Cell Death in Differentiated Human Leukemic B Cell Lines

1994 • 35 citations

Cytotoxic effect of interferon on primary malignant tumour cells. Studies in various malignancies

1993 • 34 citations

Nomenclature of the Human Interferon Genesa

1993 • 27 citations

Interaction of IFN α/β with host cells essential to the early inhibition of friend erythroleukemia visceral metastases in mice

1994 • 25 citations

Interferon system defects in malignant T-cells.

1994 • 22 citations

Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins.

1994 • 20 citations

Treatment Options for Hairy Cell Leukemia

1997 • 20 citations

Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.

1993 • 18 citations

Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.

1990 • 15 citations

Antibodies in patients with recurrent respiratory papillomatosis treated with lymphoblastoid interferon.

1991 • 13 citations

Interferon levels in human pulmonary tumors are lower than plasma levels.

1990 • 12 citations

Neutralising antibodies in patients with multiple myeloma receiving maintenance therapy with interferon α2b

1994 • 10 citations

In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.

1990 • 9 citations

Induction of 2′,5′-oligoadenylate synthetase in freshly separated malignant cells from solid tumors. Variability in the susceptibility of interferon

1987 • 9 citations

Cited By (0)

Loading...
Why Do So Many Cancer Patients Fail to Respond to Interferon Therapy? (1996) – Journal of Interferon & Cytokine Research | Metascience Observatory Explorer